US Patent 7632926 Humanized monoclonal antibodies to hepatocyte growth factor
Patent 7632926 was granted and assigned to Galaxy Biotech on December, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Hangil Park0
Kyung Jin Kim0
Lihong Wang0
Maximiliano Vasquez0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
The present invention is directed toward a humanized neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07632926 Humanized monoclonal antibodies to hepatocyte growth factor US Patent 7632926 Humanized monoclonal antibodies to hepatocyte growth factor
Infobox
Patent Number
07632926
Patent Number
7632926
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07632926 Humanized monoclonal antibodies to hepatocyte growth factor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07632926
Date of patent
December 15, 2009
Patent application number
11731774
Date Filed
March 29, 2007
Patent primary examiner
Find more entities like US Patent 7632926 Humanized monoclonal antibodies to hepatocyte growth factor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
